LT4 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 222 | 一次性ネフローゼ症候群 | 1 |
222. 一次性ネフローゼ症候群
臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000038353 | 2020-09-30 | 2020-09-21 | Effect of levothyroxine on the prognosis of children with PNS | Effect of levothyroxine on the prognosis of children with PNS | Primary nephrotic syndrome | trial group:NS basic treatment + LT4 replacement therapy;control group:after NS basic treatment for 3 weeks, LT4 replacement therapy was started; | Chidren's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China | NULL | Recruiting | 1 | 16 | Both | trial group:90;control group:90; | China |